|
|
| Welcome to the June 2010 issue of Pharmaceutical Technology Sourcing and Management, your information resource about the pharmaceutical supply chain. In this issue, we examine recent draft proposals by FDA to increase transparency in pharmaceutical manufacturing and the supply chain. Plus, the developments on the bio/pharmaceutical industry efforts in corporate social responsibility and sustainability. |
Manufacturing
FDA Considers Ways to Improve Transparency in the Supply Chain
Patricia Van Arnum, editor of Sourcing and Management and senior editor of Pharmaceutical Technology
FDA issues draft proposals on ways to improve its disclosure on information relating to import procedures, inspections, and Warning Letters.
Outsourcing
Waste Not, Want Not
Eric Langer, president of BioPlan Associates
Restructuring in the biopharmaceutical industry is renewing a focus on resource optimization.
Global Feature
CSR and Sustainability Forum
Pharmaceutical Technology’s dedicated editorial coverage on the developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, other business sectors, and other public and private organizations. This month, we feature articles on the pharmaceutical industry’s relief efforts in Haiti, the Science and Human Rights Program at the American Association for the Advancement of Science, and a roundup of CSR and sustainability news.
<< more on Haiti, the AAAS program, and a CSR roundup. >>
 |
Sourcing and Management’s Community of Experts
The panel consists of leading professionals involved in the synthesis, manufacture, and sourcing of active pharmaceutical ingredients and intermediates, and experts in formulation and dosage-form manufacturing. The community of experts lends its expertise to the eNewsletter by providing reviews of technical articles as well as offering perspectives on topics of relevance to pharmaceutical manufacturers and their suppliers.
|
Announcing Dow’s 2010 Lunch* and Learn Series |
Morning Seminars, 9AM-1PM, 3 Cities, Space is Limited
“Topical Dermatological Product Development”
See
 WWW.DOWPHARMSCI.COM for
Course Brochure and Registration Form
* Networking Luncheon included in Registration Fee
June 24th
San Diego/Del Mar, CA
June 30th
Chicago, IL
July 1st
New Brunswick, NJ
|
|
Expansion of Vetter Development Service (VDS) |
The North American market is critical to Vetter’s strategic global growth as nearly half of its client base is already located here. In order to maximize on this opportunity, Vetter has decided to create a facility, its first outside of Germany, at the Illinois Science + Technology Park in suburban Chicago. The facility, which focuses on preclinical to phase II clinical batch projects, is an expansion of Vetter Development Service. With significant progress already having been made, the facility is scheduled to be operational by beginning of the fourth quarter 2010.
 Listen Now! |
|
|
|
|
|
Pharmaceutical Technology is the authoritative source of peer-reviewed research and expert analyses for scientists, engineers, and managers engaged in process development, manufacturing, formulation, API synthesis, analytical technology, packaging, and regulatory compliance in the pharmaceutical and biotechnology industries. Subscribe Today! |
|
